צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים: lenz-tx.com (LENZ)

The presbyopia correction market is awaiting FDA approval to trigger mass demand. This TTM year-over-year revenue chart on GURU.Markets demonstrates a price vector where -29.00 represents the current metric. LENZ Therapeutics, Inc. (LENZ) revenues are based on the commercialization of drops against farsightedness. The creation of a comfortable vision ecosystem is forming a new habit, while the replacement of glasses will ensure high customer retention.
LENZ Therapeutics (LENZ) - פילוחי מדדים ודוחות פיננסיים

This metric measures the annual revenue growth rate, smoothing out quarterly volatility to assess the business's actual ability to scale revenues. By analyzing the TTM year-over-year revenue chart, an investor can see the growth dynamics of LENZ Therapeutics innovative ophthalmological drugs, which allows for an assessment of the brand's market recognition and the effectiveness of the commercialization of its unique vision-correction drops.